Literature DB >> 23530051

Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility.

Harini Krishnan1, Jhon A Ochoa-Alvarez, Yongquan Shen, Evan Nevel, Meenakshi Lakshminarayanan, Mary C Williams, Maria I Ramirez, W Todd Miller, Gary S Goldberg.   

Abstract

Podoplanin (PDPN) is a transmembrane receptor that affects the activities of Rho, ezrin, and other proteins to promote tumor cell motility, invasion, and metastasis. PDPN is found in many types of cancer and may serve as a tumor biomarker and chemotherapeutic target. The intracellular region of PDPN contains only two serines, and these are conserved in mammals including mice and humans. We generated cells from the embryos of homozygous null Pdpn knock-out mice to investigate the relevance of these serines to cell growth and migration on a clear (PDPN-free) background. We report here that one or both of these serines can be phosphorylated by PKA (protein kinase A). We also report that conversion of these serines to nonphosphorylatable alanine residues enhances cell migration, whereas their conversion to phosphomimetic aspartate residues decreases cell migration. These results indicate that PKA can phosphorylate PDPN to decrease cell migration. In addition, we report that PDPN expression in fibroblasts causes them to facilitate the motility and viability of neighboring melanoma cells in coculture. These findings shed new light on how PDPN promotes cell motility, its role in tumorigenesis, and its utility as a functionally relevant biomarker and chemotherapeutic target.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23530051      PMCID: PMC3636905          DOI: 10.1074/jbc.C112.446823

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.

Authors:  Masami Ito; Genichiro Ishii; Kanji Nagai; Ryo Maeda; Yasutaka Nakano; Atsushi Ochiai
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

2.  Nontransformed cells can normalize gap junctional communication with transformed cells.

Authors:  Virginijus Valiunas; John F Bechberger; Christian C G Naus; Peter R Brink; Gary S Goldberg
Journal:  Biochem Biophys Res Commun       Date:  2005-07-22       Impact factor: 3.575

3.  Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

Authors:  Yukinari Kato; Ganesan Vaidyanathan; Mika Kato Kaneko; Kazuhiko Mishima; Nidhi Srivastava; Vidyalakshmi Chandramohan; Charles Pegram; Stephen T Keir; Chien-Tsun Kuan; Darell D Bigner; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2010-10       Impact factor: 2.408

4.  Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.

Authors:  Haohai Liang; Hong Wu; Tamar A Giorgadze; Dinesh Sariya; Kirsten S W Bellucci; Ranjitha Veerappan; Bernadette Liegl; Geza Acs; Rosalie Elenitsas; Shruti Shukla; George A Youngberg; Philip S Coogan; Theresa Pasha; Paul J Zhang; Xiaowei Xu
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

5.  Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.

Authors:  Akinori Funayama; Jun Cheng; Satoshi Maruyama; Manabu Yamazaki; Takanori Kobayashi; Mei Syafriadi; Sukalyan Kundu; Susumu Shingaki; Chikara Saito; Takashi Saku
Journal:  Pathobiology       Date:  2011-05-26       Impact factor: 4.342

6.  Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells.

Authors:  K Nose; H Saito; T Kuroki
Journal:  Cell Growth Differ       Date:  1990-11

7.  Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.

Authors:  Akikazu Kawase; Genichiro Ishii; Kanji Nagai; Takeo Ito; Tatsuya Nagano; Yukinori Murata; Tomoyuki Hishida; Mitsuyo Nishimura; Junji Yoshida; Kazuya Suzuki; Atsushi Ochiai
Journal:  Int J Cancer       Date:  2008-09-01       Impact factor: 7.396

Review 8.  The role of podoplanin in tumor progression and metastasis.

Authors:  Marius Raica; Anca Maria Cimpean; Domenico Ribatti
Journal:  Anticancer Res       Date:  2008 Sep-Oct       Impact factor: 2.480

9.  Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators.

Authors:  Yanlin Yu; Javed Khan; Chand Khanna; Lee Helman; Paul S Meltzer; Glenn Merlino
Journal:  Nat Med       Date:  2004-01-04       Impact factor: 53.440

10.  Alterations in gene expression in T1 alpha null lung: a model of deficient alveolar sac development.

Authors:  Guetchyn Millien; Avrum Spira; Anne Hinds; Junling Wang; Mary C Williams; Maria I Ramirez
Journal:  BMC Dev Biol       Date:  2006-07-25       Impact factor: 1.978

View more
  28 in total

1.  Immunocytochemical assessment of cell differentiation of podoplanin-positive osteoblasts into osteocytes in murine bone.

Authors:  Tomoya Nagai; Tomoka Hasegawa; Tomomaya Yamamoto; Hiromi Hongo; Miki Abe; Taiji Yoshida; Ayako Yokoyama; Paulo Henrique Luiz de Freitas; Minqi Li; Atsuro Yokoyama; Norio Amizuka
Journal:  Histochem Cell Biol       Date:  2020-11-11       Impact factor: 4.304

2.  PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motility.

Authors:  Harini Krishnan; Edward P Retzbach; Maria I Ramirez; Tong Liu; Hong Li; W Todd Miller; Gary S Goldberg
Journal:  Exp Cell Res       Date:  2015-05-07       Impact factor: 3.905

3.  Independent effects of Src kinase and podoplanin on anchorage independent cell growth and migration.

Authors:  Edward P Retzbach; Stephanie A Sheehan; Harini Krishnan; Haiyan Zheng; Caifeng Zhao; Gary S Goldberg
Journal:  Mol Carcinog       Date:  2022-04-26       Impact factor: 5.139

Review 4.  The Role of Podoplanin in the Immune System and Inflammation.

Authors:  Zhiyuan Zhang; Nan Zhang; Jing Yu; Wenting Xu; Jiameng Gao; Xin Lv; Zongmei Wen
Journal:  J Inflamm Res       Date:  2022-06-17

5.  Intratumoral accumulation of podoplanin-expressing lymph node stromal cells promote tumor growth through elimination of CD4+ tumor-infiltrating lymphocytes.

Authors:  Aikaterini Hatzioannou; Saba Nayar; Anastasios Gaitanis; Francesca Barone; Constantinos Anagnostopoulos; Panayotis Verginis
Journal:  Oncoimmunology       Date:  2016-07-29       Impact factor: 8.110

Review 6.  Functional significance of the platelet immune receptors GPVI and CLEC-2.

Authors:  Julie Rayes; Steve P Watson; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

7.  Prominin-1-Radixin axis controls hepatic gluconeogenesis by regulating PKA activity.

Authors:  Hyun Lee; Dong-Min Yu; Jun Sub Park; Hwayeon Lee; Jun-Seok Kim; Hong Lim Kim; Seung-Hoi Koo; Jae-Seon Lee; Sungsoo Lee; Young-Gyu Ko
Journal:  EMBO Rep       Date:  2020-10-08       Impact factor: 8.807

Review 8.  CARP-1/CCAR1: a biphasic regulator of cancer cell growth and apoptosis.

Authors:  Magesh Muthu; Vino T Cheriyan; Arun K Rishi
Journal:  Oncotarget       Date:  2015-03-30

9.  Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.

Authors:  Kelly L Hamilton; Stephanie A Sheehan; Edward P Retzbach; Clinton A Timmerman; Garret B Gianneschi; Patrick J Tempera; Premalatha Balachandran; Gary S Goldberg
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-17       Impact factor: 4.553

10.  CLEC-2 Prevents Accumulation and Retention of Inflammatory Macrophages During Murine Peritonitis.

Authors:  Joshua H Bourne; Nonantzin Beristain-Covarrubias; Malou Zuidscherwoude; Joana Campos; Ying Di; Evelyn Garlick; Martina Colicchia; Lauren V Terry; Steven G Thomas; Alexander Brill; Jagadeesh Bayry; Steve P Watson; Julie Rayes
Journal:  Front Immunol       Date:  2021-06-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.